Kelly D. Mullen;Philip Cox;Michael Z. Hoemann;Anil Vasudevan;Gagandeep Somal;Noel S. Wilson;Clara I. Villamil;Bruce Clapham;David J. Calderwood;Bin Li
发明人:
David J. Calderwood,Noel S. Wilson,Philip Cox,Michael Z. Hoemann,Bruce Clapham,Anil Vasudevan,Clara I. Villamil,Bin Li,Gagandeep Somal,Kelly D. Mullen
申请号：
US13268387
公开号：
US20120122846A1
申请日:
2011.10.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention is directed to novel compounds of Formula (I)pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
